1. Market Research
  2. > Healthcare Market Trends
  3. > United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the United States In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 15
2 Introduction 18
2.1 What Is This Report About? 18
2.2 In Vitro Diagnostics Market Segmentation 18
2.3 Definitions of Markets Covered in the Report 21
3 In Vitro Diagnostics Market, United States 34
3.1 In Vitro Diagnostics Market, United States, Revenue ($m), 2007-2021 34
3.2 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2014 36
3.3 In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2014 37
3.4 In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2007-2021 39
3.5 In Vitro Diagnostics Market, United States, Revenue ($m), 2007-2014 41
3.6 In Vitro Diagnostics Market, United States, Revenue ($m), 2014-2021 43
3.7 In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), 2014 45
4 Clinical Chemistry Market, United States 47
4.1 Clinical Chemistry Market, United States, Revenue Mix ($m), 2014 47
4.2 Clinical Chemistry Market, United States, Segment Contribution (%), 2014 48
4.3 Clinical Chemistry Market, United States, Revenue ($m), 2007-2014 49
4.4 Clinical Chemistry Market, United States, Revenue ($m), 2014-2021 51
4.5 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2013-2014 65
4.6 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2014 66
5 Genetic Testing Market, United States 68
5.1 Genetic Testing Market, United States, Revenue Mix ($m), 2014 68
5.2 Genetic Testing Market, United States, Segment Contribution (%), 2014 69
5.3 Genetic Testing Market, United States, Revenue ($m), 2007-2014 70
5.4 Genetic Testing Market, United States, Revenue ($m), 2014-2021 72
5.5 Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2013-2014 74
5.6 Genetic Testing Market, United States, Company Share by Revenue ($m), 2014 75
6 Haematology Market, United States 77
6.1 Haematology Market, United States, Revenue Mix ($m), 2014 77
6.2 Haematology Market, United States, Segment Contribution (%), 2014 78
6.3 Haematology Market, United States, Revenue ($m), 2007-2014 79
6.4 Haematology Market, United States, Revenue ($m), 2014-2021 81
6.5 Haematology Market, United States, Distribution Share by Revenue ($m), 2013-2014 103
6.6 Haematology Market, United States, Company Share by Revenue ($m), 2014 104
7 Histology And Cytology Market, United States 106
7.1 Histology And Cytology Market, United States, Revenue Mix ($m), 2014 106
7.2 Histology And Cytology Market, United States, Segment Contribution (%), 2014 107
7.3 Histology and Cytology Market, United States, Revenue ($m), 2007-2014 108
7.4 Histology and Cytology Market, United States, Revenue ($m), 2014-2021 110
7.5 Histology and Cytology Market, United States, Distribution Share by Revenue ($m), 2013-2014 112
7.6 Histology and Cytology Market, United States, Company Share by Revenue ($m), 2014 113
8 Immuno Chemistry Market, United States 115
8.1 Immuno Chemistry Market, United States, Revenue Mix ($m), 2014 115
8.2 Immuno Chemistry Market, United States, Segment Contribution (%), 2014 116
8.3 Immuno Chemistry Market, United States, Revenue ($m), 2007-2014 118
8.4 Immuno Chemistry Market, United States, Revenue ($m), 2014-2021 120
8.5 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2013-2014 150
8.6 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2014 151
9 Infectious Diagnostics Market, United States 153
9.1 Infectious Diagnostics Market, United States, Revenue Mix ($m), 2014 153
9.2 Infectious Diagnostics Market, United States, Segment Contribution (%), 2014 154
9.3 Infectious Diagnostics Market, United States, Revenue ($m), 2007-2014 156
9.4 Infectious Diagnostics Market, United States, Revenue ($m), 2014-2021 158
8.5 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2013-2014 164
8.6 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2014 165
10 Microbiology Culture Market, United States 167
10.1 Microbiology Culture Market, United States, Revenue Mix ($m), 2014 167
10.2 Microbiology Culture Market, United States, Segment Contribution (%), 2014 168
10.3 Microbiology Culture Market, United States, Revenue ($m), 2007-2014 170
10.4 Microbiology Culture Market, United States, Revenue ($m), 2014-2021 172
10.5 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2013-2014 178
10.6 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2014 179
11 Overview of Key Companies in United States, In Vitro Diagnostics Market 181
11.1 Siemens Healthcare 181
11.2 F. Hoffmann-La Roche Ltd. 181
11.3 Danaher Corporation 181
11.4 Abbott Laboratories 182
11.5 Becton, Dickinson and Company 182
11.6 Hologic, Inc. 182
11.7 bioMerieux S.A. 183
11.8 Qiagen N.V. 183
11.9 Bio-Rad Laboratories, Inc. 183
11.10 Alere Inc. 184
11.11 Thermo Fisher Scientific Inc. 184
11.12 Immucor, Inc. 184
11.13 Ortho-Clinical Diagnostics Inc. 185
11.14 Sysmex Corporation 185
11.15 Cepheid 185
11.16 PerkinElmer, Inc. 186
12 In Vitro Diagnostics Market Pipeline Products 187
13 Financial Deals Landscape 193
13.1 Acquisition 193
13.2 Asset Transactions 253
13.3 Debt Offerings 268
13.4 Equity Offerings 313
13.5 Merger 397
13.6 Partnerships 399
13.7 Private Equity 554
13.8 Venture Financing 556
14 Appendix 665
14.1 Research Methodology 666
14.2 GlobalData Consulting 667
14.3 Contact Us 668
14.4 Disclaimer 668

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2007-2021 47
Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2014 50
Table 3: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), USD Constant, 2007-2021 52
Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 6: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2014 58
Table 7: Clinical Chemistry Market, United States, Segment Contribution (%), 2014 60
Table 8: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 62
Table 9: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 64
Table 10: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 11: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 68
Table 12: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 70
Table 13: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Table 14: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Table 15: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 76
Table 16: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 77
Table 17: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2014 79
Table 18: Genetic Testing Market, United States, Segment Contribution (%), 2014 81
Table 19: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 20: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 85
Table 21: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 86
Table 22: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2014 88
Table 23: Haematology Market, United States, Segment Contribution (%), 2014 90
Table 24: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 92
Table 25: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 26: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 96
Table 27: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 98
Table 28: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 100
Table 29: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 102
Table 30: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 104
Table 31: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Table 32: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Table 33: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 110
Table 34: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 112
Table 35: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 114
Table 36: Haematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 115
Table 37: Haematology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 117
Table 38: Histology And Cytology Market, United States, Segment Contribution (%), 2014 119
Table 39: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 40: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 123
Table 41: Histology and Cytology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 124
Table 42: Histology and Cytology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 126
Table 43: Immuno Chemistry Market, United States, Segment Contribution (%), 2014 129
Table 44: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 45: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Table 46: Anemia Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 135
Table 47: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 137
Table 48: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 139
Table 49: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 141
Table 50: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 143
Table 51: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 145
Table 52: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 147
Table 53: Anemia Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 149
Table 54: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 151
Table 55: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 153
Table 56: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Table 57: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Table 58: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 159
Table 59: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 161
Table 60: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 162
Table 61: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2014 164
Table 62: Infectious Diagnostics Market, United States, Segment Contribution (%), 2014 167
Table 63: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 169
Table 64: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Table 65: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 173
Table 66: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 175
Table 67: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 176
Table 68: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2014 178
Table 69: Microbiology Culture Market, United States, Segment Contribution (%), 2014 181
Table 70: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 183
Table 71: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 185
Table 72: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 187
Table 73: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 189
Table 74: Microbiology Culture Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 190
Table 75: Microbiology Culture Market, United States, Company Share by Revenue ($m), USD Constant, 2014 192
Table 76: In Vitro Diagnostics Market Pipeline Products 199
Table 77: OpGen Acquires AdvanDx 205
Table 78: Charles River Labs Acquires Celsis International for USD212 Million 207
Table 79: Alere Acquires US Diagnostics USD60 Million 209
Table 80: Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million 210
Table 81: Bio-Techne to Acquire Cliniqa 212
Table 82: Beijing Bohui Innovation Acquires Advion for USD28 Million 213
Table 83: Unchained Labs Acquires AVIA Biosystems 214
Table 84: Bioheart to Acquire Pavillion Scientific 215
Table 85: Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 216
Table 86: Eurofins Scientific to Acquire Diatherix Labs for USD50 Million 219
Table 87: Quest Diagnostics May Sell itself 220
Table 88: GeneNews and Cobalt Healthcare Acquire 33% Stake in Innovative Diagnostic Labs from Health Diagnostic Labs for USD4 Million 221
Table 89: Progen Pharma to Acquire TBG 223
Table 90: Progenity Acquires Carmenta Bioscience 224
Table 91: Illinois Health and Science Acquires IBA Molecular North America from IBA Molecular 225
Table 92: Roche Acquires CAPP Medical 226
Table 93: Rosetta Genomics Acquires PersonalizeDx from Prelude 227
Table 94: Global Enterprises to Acquire Majority Stake in Predictive Therapeutics 228
Table 95: Vivione Biosciences Announces the Expiration of Agreement to Acquire Trillium Diagnostics for USD15 Million 229
Table 96: Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 230
Table 97: DNA Electronics Acquires NanoMR for up to USD24 Million 231
Table 98: Amarantus BioScience Acquires DioGenix 232
Table 99: Adaptive Biotech Acquires Sequenta 233
Table 100: Aegis Sciences Corporation Acquires Diagnovus 235
Table 101: Roche Acquires Bina Technologies 236
Table 102: Eurofins Scientific Acquires Boston Heart Diagnostics 237
Table 103: LabCorp Acquires Bode Technology from SolutionPoint 239
Table 104: Roche Acquires Ariosa Diagnostics 240
Table 105: Noble Life Sciences Acquires Spring Valley Labs 241
Table 106: IBM Watson Invests in Pathway Genomics 242
Table 107: LabCorp Acquires Covance for USD6.1 Billion 243
Table 108: PDI Acquires RedPath Integrated Pathology for USD23 Million 245
Table 109: Optum to Acquire Alere for USD600 Million 247
Table 110: Sigma-Aldrich Acquires Cell Marque 249
Table 111: Immucor Acquires Sentilus 250
Table 112: Neogen Acquires BioLumix 251
Table 113: LabCorp Acquires LipoScience for USD85.3 Million 252
Table 114: Merck to Acquire Sigma-Aldrich for USD17 Billion 254
Table 115: Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 256
Table 116: Veracyte Acquires Allegro Diagnostics for USD21 Million 257
Table 117: Nanosphere Plans to Sell Itself 258
Table 118: American Liberty Petroleum Acquires Avant Diagnostics 259
Table 119: Orgentec Diagnostika to Acquire Corgenix Medical for USD16 Million 260
Table 120: Roper Industries Acquires Innovative Product Achievements 262
Table 121: WholeHealth Products Acquires Rapid Results, Medical Diagnostic Distribution Company 264
Table 122: Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs 265
Table 123: Xagenic Acquires Rights to Detection Technology from University of Toronto 266

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2007-2021 46
Figure 2: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2014 48
Figure 3: In Vitro Diagnostics Market, United States, Category Contribution (%), 2014 49
Figure 4: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), USD Constant, 2007-2021 51
Figure 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 6: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 7: In Vitro Diagnostics Market, United States, Company Share (%) 2014 57
Figure 8: Clinical Chemistry Market, United States, Revenue Mix ($m), 2014 59
Figure 9: Clinical Chemistry Market, United States, Segment Contribution (%), 2014 60
Figure 10: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 61
Figure 11: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 63
Figure 12: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 13: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 67
Figure 14: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 69
Figure 15: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Figure 16: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Figure 17: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 75
Figure 18: Clinical Chemistry Market, United States, Company Share (%) 2014 78
Figure 19: Genetic Testing Market, United States, Revenue Mix ($m), 2014 80
Figure 20: Genetic Testing Market, United States, Segment Contribution (%), 2014 81
Figure 21: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 22: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 84
Figure 23: Genetic Testing Market, United States, Company Share (%) 2014 87
Figure 24: Haematology Market, United States, Revenue Mix ($m), 2014 89
Figure 25: Haematology Market, United States, Segment Contribution (%), 2014 90
Figure 26: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 91
Figure 27: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 28: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 95
Figure 29: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 97
Figure 30: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 99
Figure 31: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 101
Figure 32: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 103
Figure 33: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 105
Figure 34: Haematology Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Figure 35: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 109
Figure 36: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 111
Figure 37: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 113
Figure 38: Haematology Market, United States, Company Share (%) 2014 116
Figure 39: Histology And Cytology Market, United States, Revenue Mix ($m), 2014 118
Figure 40: Histology And Cytology Market, United States, Segment Contribution (%), 2014 119
Figure 41: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 42: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 122
Figure 43: Histology and Cytology Market, United States, Company Share (%) 2014 125
Figure 44: Immuno Chemistry Market, United States, Revenue Mix ($m), 2014 127
Figure 45: Immuno Chemistry Market, United States, Segment Contribution (%), 2014 128
Figure 46: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 130
Figure 47: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Figure 48: Anemia Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 134
Figure 49: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 136
Figure 50: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 138
Figure 51: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 140
Figure 52: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 142
Figure 53: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 144
Figure 54: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 146
Figure 55: Anemia Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 148
Figure 56: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 150
Figure 57: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 152
Figure 58: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Figure 59: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Figure 60: Immunochemistry Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Figure 61: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 160
Figure 62: Immuno Chemistry Market, United States, Company Share (%) 2014 163
Figure 63: Infectious Diagnostics Market, United States, Revenue Mix ($m), 2014 165
Figure 64: Infectious Diagnostics Market, United States, Segment Contribution (%), 2014 166
Figure 65: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 168
Figure 66: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 170
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 172
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 174
Figure 69: Infectious Diagnostics Market, United States, Company Share (%) 2014 177
Figure 70: Microbiology Culture Market, United States, Revenue Mix ($m), 2014 179
Figure 71: Microbiology Culture Market, United States, Segment Contribution (%), 2014 180
Figure 72: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 182
Figure 73: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 184
Figure 74: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 186
Figure 75: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 188
Figure 76: Microbiology Culture Market, United States, Company Share (%) 2014 191

Companies Mentioned
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Abbott Laboratories
Becton, Dickinson and Company
Hologic, Inc.
bioMerieux S.A.
Qiagen N.V.
Bio-Rad Laboratories, Inc.
Alere Inc.
Thermo Fisher Scientific Inc.
Immucor, Inc.
Ortho-Clinical Diagnostics Inc.
Sysmex Corporation
Cepheid
PerkinElmer, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.